LSTM opens $23m robotic AI lab for infections research

The LSTM in the UK has opened a £20m ($23.2m) robotic AI laboratory to test drugs and vaccines against infections and diseases. The laboratory is expected to open in 2027 and create new jobs in the region. Researchers and companies will use human organoids, tissue cultures grown in the laboratory, to assess potential treatments. Credit: Liverpool School of Tropical Medicine (LSTM). The Liverpool School of Tropical Medicine (LSTM) in the UK has opened a £20m ($23.2m) robotic AI laboratory to test drugs and vaccines against infections and diseases. The Liverpool Accelerate Laboratory was developed with the LSTM-led iiCON: Infection Innovation…

Source: Pharmaceutical Technology